Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing or treating cancer containing extracellular polysaccharide produced by ceriporia lacerata as active ingredient

A technology for tearing C. cereus and exopolysaccharides, which can be applied to medical preparations containing active ingredients, drug combinations, organic active ingredients, etc., and can solve the problem that the effect of preventing or treating cancer has not been reported yet.

Active Publication Date: 2017-09-19
福健生物制药有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In relation to the medical treatment use of the fungus, only the use of the culture solution extract of the fungus for the treatment of diabetes disclosed in Korean Registered Patent No. 10-1031605 filed by the inventor of the present invention has been widely known so far , while the use of P. cereus to prevent or treat cancer has not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing or treating cancer containing extracellular polysaccharide produced by ceriporia lacerata as active ingredient
  • Pharmaceutical composition for preventing or treating cancer containing extracellular polysaccharide produced by ceriporia lacerata as active ingredient
  • Pharmaceutical composition for preventing or treating cancer containing extracellular polysaccharide produced by ceriporia lacerata as active ingredient

Examples

Experimental program
Comparison scheme
Effect test

manufacture example 1

[0063] Production Example 1. Production of Mycelia Culture Liquid

[0064] The mucormyces cultured by subculturing the Mucoralus cereus separated from live tissues of oak trees collected in Sangju, Gyeongsangbuk-do (Korea) were frozen and stored at -80°C, and the stored strains were stored at -80°C. PDA (Potatodextrose agar) medium (87 plastic Petri dishes; culture medium (Difco), Becton Dickinson Company (Becton Dickinson and Company)) after passage 2 to 3 times, strain (hereinafter referred to as "PDA culture strain") Store in a 4°C refrigerator before use. And after forming PDB (Potato dextrose broth) medium (Difco, Becton Dickinson and Company) 600ml in Erlenmeyer flask, put a PDA culture strain here, and carry out the shock culture of eight days at 25 ℃, thus obtained PDB culture strains.

[0065]In addition, for the cultivation of the strain, the liquid culture medium was used in an 800l fermenter at 1.5kgf / cm 2 After injecting air at 121°C and sterilizing for 20 minu...

manufacture example 2

[0066] Production example 2. Production of dry powder of the culture solution of Ceruleus spp.

[0067] Using a vacuum freeze dryer, the mycelia culture solution of Ceruleus cerevisiae produced in Production Example 1 was subjected to vacuum freeze-drying at 25° C. for 72 hours to make it powder, thus producing cervus cerevisiae Dry powder of fungus mycelium culture fluid.

manufacture example 3

[0068] Production example 3. Production of the culture solution extract of Ceruleus lamina

[0069] 100 ml of distilled water was added to 5 g of the dry powder of the culture solution of the cerebrospora mycelium produced in the above-mentioned production example 2, and after suspending sufficiently, centrifugation was performed at 8,000 rpm for 20 minutes, and the supernatant Add ethanol equivalent to 2 to 3 times the amount, and let it stand at 4°C for 12 hours. Thereafter, the supernatant was extracted from the standing matter to produce an extract of the culture solution of the mycelia of C. cerevisiae.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to View More

Abstract

Systems and methods for pumping milk from a breast, wherein the milk is expressed from the breast under suction and milk is expulsed from the pumping mechanism to a collection container under positive pressure.

Description

technical field [0001] The present invention relates to a pharmaceutical composition for preventing or treating cancer. The pharmaceutical composition for preventing or treating cancer contains the following active ingredients: exopolysaccharide produced by Ceriporia lacerata, comprising The mycelia culture solution of the exopolysaccharide, the mycelia culture solution, the dry powder of the mycelia culture solution, or the extract of the mycelia culture solution. Background technique [0002] Cancer is a general term for a group of diseases that may take the life of an individual by destroying surrounding normal tissues or organs through a mass or tumor caused by a variety of causes Composed of undifferentiated cells that proliferate indefinitely. Chemotherapy against cancer relies on the administration of anticancer substances exhibiting strong cytotoxicity, and has a problem of causing many side effects. Therefore, there is a need to develop new anticancer agents capab...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/07A61P35/00A23L31/00A23L33/125
CPCA23V2002/00A61K36/07A23L31/00A23L33/125A23V2200/308A23V2250/208A23V2250/51A61K31/7004A61K31/7008A61K36/06
Inventor 金润秀
Owner 福健生物制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com